| Heather C Hanshaw, CCC-SLP | |
|
6223 Slater St, Merriam, KS 66202-2848 | |
| (913) 620-1007 | |
| (913) 273-0798 |
| Full Name | Heather C Hanshaw |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6223 Slater St, Merriam, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093498271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4379 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather C Hanshaw, CCC-SLP 4902 W 57th St, Roeland Park, KS 66205-2827 Ph: (913) 548-8842 | Heather C Hanshaw, CCC-SLP 6223 Slater St, Merriam, KS 66202-2848 Ph: (913) 620-1007 |
News Archive
A new study at Tel Aviv University found that eosinophils - a type of white blood cells - are recruited to the battle against cancer metastases in the lungs.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
An analysis of federal data from the Department of Health and Human Services by NPR's Investigative Unit found that there's one age group that's going into nursing homes at a higher rate. And it's not the elderly (Shapiro, 12/9).
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
› Verified 7 days ago
Kathleen M Ballard, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St, #250, Merriam, KS 66204 Phone: 913-894-1910 Fax: 877-913-1174 | |
Mrs. Priscilla Rayburn Dipasquale, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6700 Antioch Rd, Suite 120, Merriam, KS 66204 Phone: 913-652-9229 Fax: 888-652-9198 | |
Nathaniel Fuji Sato, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St, Suite 250, Merriam, KS 66204 Phone: 913-894-1910 Fax: 913-894-1174 | |
Rachel M Mcglashen, MA, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St, Suite 250, Merriam, KS 66204 Phone: 913-894-1910 Fax: 913-894-1174 | |
Courtney Michelle Root, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 121, Merriam, KS 66204 Phone: 913-362-7518 | |
Sydney Fancher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10000 W 75th St Ste 250, Merriam, KS 66204 Phone: 913-894-1910 |